Frontier Medicines Company

Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development, enabling patients to consume breakthrough medicines that redefine the course of debilitating diseases.
Technology: Artificial Intelligence, Biotechnology, Pharmaceutical
Industry: Data Processing, Early Drug Development
Headquarters: San Francisco, California, United States
Founded Date: 2018-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 10
Total Funding: 155500000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-07-19
Last Funding Type: Series B

Visit Website
Register and Claim Ownership